Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo García-Jaén

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Platelets|December 23, 2025
Immune thrombocytopenia triggered by dostarlimab in a patient with endometrial carcinoma: first reported caseAdolfo Fernández-Sánchez, Pablo García-Jaén, Carlos Puerta-Vázquez, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2025
A novel homozygous splice-site variant in VPS33B identified as a cause of bleedingLorena Díaz-Ajenjo, Ana Marín-Quílez, Ana Lama-Villanueva, et al.
Research and Practice in Thrombosis and Haemostasis|July 11, 2026
Efficacy and safety of recombinant activated factor VII for secondary prophylaxis in patients with Glanzmann thrombastheniaPablo García-Jaén, Nuria Fernández-Mosteirin, María Luisa Serrano, et al.
Thrombosis and Haemostasis|December 24, 2025
Optimizing Surgical Approaches for Patients with Inherited Factor VII DeficiencyPablo García-Jaén, José Manuel Martín de Bustamante, Ana Mendoza-Martínez, et al.
British Journal of Haematology|May 30, 2026
Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI)Cristina Pascual-Izquierdo, José-María Bastida, David Valcárcel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Platelets|December 23, 2025
Immune thrombocytopenia triggered by dostarlimab in a patient with endometrial carcinoma: first reported caseAdolfo Fernández-Sánchez, Pablo García-Jaén, Carlos Puerta-Vázquez, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2025
A novel homozygous splice-site variant in VPS33B identified as a cause of bleedingLorena Díaz-Ajenjo, Ana Marín-Quílez, Ana Lama-Villanueva, et al.
Research and Practice in Thrombosis and Haemostasis|July 11, 2026
Efficacy and safety of recombinant activated factor VII for secondary prophylaxis in patients with Glanzmann thrombastheniaPablo García-Jaén, Nuria Fernández-Mosteirin, María Luisa Serrano, et al.
Thrombosis and Haemostasis|December 24, 2025
Optimizing Surgical Approaches for Patients with Inherited Factor VII DeficiencyPablo García-Jaén, José Manuel Martín de Bustamante, Ana Mendoza-Martínez, et al.
British Journal of Haematology|May 30, 2026
Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI)Cristina Pascual-Izquierdo, José-María Bastida, David Valcárcel, et al.
Pageof 1